{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:03:31Z","timestamp":1781521411241,"version":"3.54.1"},"reference-count":20,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100012774","name":"Innovation Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,18]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Serum insulin-like factor 3 (INSL3) is a Leydig cell biomarker, but little is known about the circulating concentration of INSL3 during hypothalamus-pituitary-testicular suppression.<\/jats:p>\n <\/jats:sec>\n \n Aim<\/jats:title>\n To study the concomitant changes in serum concentrations of INSL3, testosterone, and LH during experimental and therapeutic testicular suppression.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We included serum samples from 3 different cohorts comprising subjects before and after testicular suppression: (1) 6 healthy young men who were treated with androgens (Sustanon, Aspen Pharma, Dublin, Ireland); 2) 10 transgender girls (male sex assigned at birth) who were treated with 3-monthly GnRH agonist injections (Leuprorelinacetat, Abacus Medicine, Copenhagen, Denmark); and (3) 55 patients with prostate cancer who were randomized to surgical castration (bilateral subcapsular orchiectomy) or treatment with GnRH agonist (Triptorelin, Ipsen Pharma, Kista, Sweden). Serum INSL3 and testosterone concentrations were quantified in stored serum samples using validated liquid chromatography-tandem mass spectrometry methodologies, and LH was measured by an ultrasensitive immunoassay.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The circulating concentrations of INSL3, testosterone, and LH decreased during experimental testicular suppression in healthy young men by Sustanon injections and subsequently returned to baseline levels after release of suppression. All 3 hormones decreased during therapeutic hormonal hypothalamus-pituitary-testicular suppression in transgender girls and in patients with prostate cancer.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n INSL3 resembles testosterone as a sensitive marker of testicular suppression and reflects Leydig cell function, also during exposure to exogenous testosterone. Serum INSL3 measurements may complement testosterone as a Leydig cell marker in male reproductive disorders, during therapeutic testicular suppression as well as in surveillance of illicit use of androgens.<\/jats:p>\n <\/jats:sec>","DOI":"10.1210\/clinem\/dgad291","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T19:24:08Z","timestamp":1685129048000},"page":"2834-2839","source":"Crossref","is-referenced-by-count":7,"title":["Serum Insulin-like Factor 3, Testosterone, and LH in Experimental and Therapeutic Testicular Suppression"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-1128","authenticated-orcid":false,"given":"Jakob","family":"Albrethsen","sequence":"first","affiliation":[{"name":"Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, 2100 Copenhagen, Denmark"},{"name":"International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Busch","family":"\u00d8stergren","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Department of Urology, Copenhagen University Hospital \u2013 2730 Herlev and Gentofte, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille Badsberg","family":"Norup","sequence":"additional","affiliation":[{"name":"Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, 2100 Copenhagen, Denmark"},{"name":"International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"S\u00f8nksen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Department of Urology, Copenhagen University Hospital \u2013 2730 Herlev and Gentofte, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Fode","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Department of Urology, Copenhagen University Hospital \u2013 2730 Herlev and Gentofte, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3019-6775","authenticated-orcid":false,"given":"Caroline","family":"Kistorp","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Department of Endocrinology, Copenhagen University Hospital \u2013 Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai B","family":"Nordsborg","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Amalie","family":"Solheim","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark"},{"name":"Science and Research, Anti Doping Denmark, Br\u00f8ndby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"M\u00f8rkeberg","sequence":"additional","affiliation":[{"name":"Science and Research, Anti Doping Denmark, Br\u00f8ndby, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina M","family":"Main","sequence":"additional","affiliation":[{"name":"Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, 2100 Copenhagen, Denmark"},{"name":"International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0534-4350","authenticated-orcid":false,"given":"Anders","family":"Juul","sequence":"additional","affiliation":[{"name":"Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, 2100 Copenhagen, Denmark"},{"name":"International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Rigshospitalet and University of Copenhagen, 2100 Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"issue":"4","key":"2023122021572584400_dgad291-B1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/humupd\/dmp011","article-title":"Biology of insulin-like factor 3 in human reproduction","volume":"15","author":"Ivell","year":"2009","journal-title":"Hum Reprod Update"},{"issue":"5","key":"2023122021572584400_dgad291-B2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.urology.2004.06.051","article-title":"Mutation analysis of INSL3 and GREAT\/LGR8 genes in familial cryptorchidism","volume":"64","author":"Feng","year":"2004","journal-title":"Urology"},{"issue":"11","key":"2023122021572584400_dgad291-B3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jmedgenet-2019-106203","article-title":"Familial bilateral cryptorchidism is caused by recessive variants in RXFP2","volume":"56","author":"Ayers","year":"2019","journal-title":"J Med Genet"},{"issue":"19","key":"2023122021572584400_dgad291-B4","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1073\/pnas.0307061101","article-title":"Paracrine regulation of mammalian oocyte maturation and male germ cell survival","volume":"101","author":"Kawamura","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2023122021572584400_dgad291-B5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1359\/jbmr.080204","article-title":"Mutations in the insulin-like factor 3 receptor are associated with osteoporosis","volume":"23","author":"Ferlin","year":"2008","journal-title":"J Bone Miner Res"},{"key":"2023122021572584400_dgad291-B6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fendo.2018.00562","article-title":"Protective role of testicular hormone INSL3 from atrophy and weakness in skeletal muscle","volume":"9","author":"Ferlin","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2023122021572584400_dgad291-B7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/andr.12597","article-title":"AMH And INSL3 in testicular and extragonadal pathophysiology: what do we know?","volume":"7","author":"Sansone","year":"2019","journal-title":"Andrology"},{"issue":"6","key":"2023122021572584400_dgad291-B8","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1210\/jc.2004-2257","article-title":"Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis","volume":"90","author":"Bay","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2023122021572584400_dgad291-B9","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1210\/jc.2013-2288","article-title":"Insulin-like peptide 3 (INSL3) in men with congenital hypogonadotropic hypogonadism\/Kallmann syndrome and effects of different modalities of hormonal treatment: a single-center study of 281 patients","volume":"99","author":"Trabado","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023122021572584400_dgad291-B10","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1210\/clinem\/dgaa145","article-title":"Evaluation of serum insulin-like factor 3 quantification by LC-MS\/MS as a biomarker of Leydig cell function","volume":"105","author":"Albrethsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2023122021572584400_dgad291-B11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2605.2006.00714.x","article-title":"Peripheral INSL3 concentrations decline with age in a large population of Australian men","volume":"29","author":"Anand-Ivell","year":"2006","journal-title":"Int J Androl"},{"key":"2023122021572584400_dgad291-B12","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.563620","article-title":"An intramuscular injection of mixed testosterone esters does not acutely enhance strength and power in recreationally active young men","volume":"11","author":"Solheim","year":"2020","journal-title":"Front Physiol"},{"issue":"6","key":"2023122021572584400_dgad291-B13","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.juro.2016.12.003","article-title":"Luteinizing hormone-releasing hormone agonists are superior to subcapsular orchiectomy in lowering testosterone levels of men with prostate cancer: results from a randomized clinical trial","volume":"197","author":"\u00d8stergren","year":"2017","journal-title":"J Urol"},{"issue":"11","key":"2023122021572584400_dgad291-B14","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1515\/cclm-2018-0171","article-title":"Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum","volume":"56","author":"Albrethsen","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"2023122021572584400_dgad291-B15","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/andr.13220","article-title":"Association of age, hormonal and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European male aging study cohort","volume":"10","author":"Anand-Ivell","year":"2022","journal-title":"Andrology"},{"issue":"3","key":"2023122021572584400_dgad291-B16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/jc.2005-1865","article-title":"The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men","volume":"91","author":"Bay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023122021572584400_dgad291-B17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fertnstert.2012.09.009","article-title":"Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial","volume":"99","author":"Roth","year":"2013","journal-title":"Fertil Steril"},{"issue":"12","key":"2023122021572584400_dgad291-B18","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1210\/jc.2004-0575","article-title":"A novel circulating hormone of testis origin in humans","volume":"89","author":"Foresta","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023122021572584400_dgad291-B19","doi-asserted-by":"crossref","first-page":"e2664","DOI":"10.1210\/clinem\/dgab129","article-title":"Serum insulin-like factor 3 levels are reduced in former androgen users, suggesting impaired Leydig cell capacity","volume":"106","author":"Rasmussen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"11-12","key":"2023122021572584400_dgad291-B20","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/dta.1914","article-title":"Detection of testosterone esters in blood","volume":"7","author":"Forsdahl","year":"2015","journal-title":"Drug Test Anal"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad291\/50539223\/dgad291.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/11\/2834\/54694995\/dgad291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/11\/2834\/54694995\/dgad291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T22:06:30Z","timestamp":1703109990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/11\/2834\/7180820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,5,26]]},"published-print":{"date-parts":[[2023,10,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad291","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,5,26]]}}}